Visualitza per autor "McGregor, Bradley"
Ara mostrant els elements 1-2 d 2
-
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer
Carles Galceran, Joan; Chowdhury, Simon; McGregor, Bradley; Merseburger, Axel; Agarwal, Neeraj; Azad, Arun (Future Medicine, 2022-03) -
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma
Geynisman, Daniel M.; Burotto, Mauricio; Suárez Rodríguez, Cristina; Bourlon, Maria T.; Porta, Camillo; McGregor, Bradley (Oxford University Press, 2023-01)